We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TLS:NASDAQTelos Corporation Analysis

Data as of 2026-09-16 - not real-time

$4.08

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Telos Corporation trades at $4.08, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 16.4% over the past 30 days. Momentum indicators put RSI at 39.8 (approaching oversold) with MACD reading bearish. Watch $3.94 as support and $5.13 as the nearer resistance level.
On valuation the read is undervalued — earnings multiple of 15.8 versus a 32.8 sector average, below the peer group. Analyst price targets sit 55.2% above the current price. Revenue is growing at 32.7% on a -8.1% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 88.1%, a beta of 1.54 and a maximum drawdown of 50.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 2/10.

Top Market Events

Telos Corp TLS exceeds Q2 2026 guidance with strong free cash flow and raises full-year adjusted EBITDA outlook.Revenue surged 33% as management exits low-margin software resale.Telos Corporation TLS came out with quarterly earnings of $0.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 4.68
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 15.8 versus sector average of 32.8
  • Trading below the 200-day average of 4.68

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 15.8 versus sector average of 32.8
  • Negative profit margin of -8.1%
  • Analyst targets imply +55.2% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth32.70%
Profit Margin-8.13%
P/E Ratio15.8
ROE-14.86%
ROA-1.56%
Debt/Equity7.46
P/B Ratio3.3
Op. Cash Flow$34.6M
Free Cash Flow$24.8M
Industry P/E32.8

Technical Analysis

TrendBearish
RSI39.8
Support$3.94
Resistance$5.13
MA 20$4.53
MA 50$4.57
MA 200$4.68
MACDBearish
VolumeIncreasing
Fear & Greed Index91.52

Valuation

Fair Value$11.72
Target Price$6.33
Upside/Downside55.23%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta1.54
Volatility88.09%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.